Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC

Fig. 2

Cumulative Kaplan-Meier plot of survival from the initial pathological diagnosis. Using a TLC nadir of ≤500 as a cutoff, patients with severe lymphopenia during RT had significantly worse progression-free survival (PFS) and overall survival (OS), compared to those who did not (P = 0.003, P = 0.008, respectively) (a and b). Patients treated with short-course radiotherapy (overall treatment time was within 4 weeks) had longer median PFS and OS trends than patients with long-course radiotherapy (overall treatment time was more than 4 weeks) (P = 0.136, P = 0.071, respectively) (c and d)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us